ABUS vs CMS
Arbutus Biopharma Corp (ABUS) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
CMS does not have a complete income-statement cache yet.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the ABUS and CMS stock pages for the full models.
Not investment advice.